Huperzine A: A Supplement in the U.S., a Dementia Drug in China
Why the last ingredient on the MindVault list is the one that deserves the most respect.
From club moss tea to clinic
Huperzia serrata, a small club moss, was used in traditional Chinese medicine for fever and swelling. In the 1980s, Chinese chemists isolated huperzine A and found it to be a potent, reversible inhibitor of acetylcholinesterase, the enzyme that breaks down the memory messenger acetylcholine. That is precisely how donepezil, rivastigmine and galantamine work[6]. China went on to approve huperzine A as a medicine for Alzheimer's disease, and dozens of Chinese trials followed[1].
What the trials found, and why reviewers are cautious
A 2013 meta-analysis of 20 randomized trials, almost all from China, found better scores on standard cognitive scales in people with Alzheimer's disease taking huperzine A, typically 200 to 400 mcg a day, for 8 to 36 weeks[1]. A small trial in vascular dementia reported similar improvements[5]. Reviewers were less impressed by the trials themselves: small samples, short follow-up and unclear methods. The Cochrane review found the evidence too weak to recommend use[3], and a 2021 overview of systematic reviews reached the same conclusion about quality[4].
The one large Western trial, run by the U.S. Alzheimer's Disease Cooperative Study, randomized 210 people with mild to moderate Alzheimer's to placebo, 200 mcg twice a day or 400 mcg twice a day. The primary dose showed no benefit at 16 weeks; the higher dose showed an improvement at 11 weeks in a secondary analysis that faded by week 16[2].
How a drug ends up in a supplement
In the U.S., huperzine A is sold as a dietary supplement, which means no pre-market review of safety or effectiveness and no requirement to state a dose on the front of the label[8]. The result is an odd situation: the same compound that is a prescription medicine in one country is sold alongside vitamins in another, often without the warnings that would come with the prescription version.
Side effects and interactions
Because it acts like the prescription cholinesterase inhibitors, huperzine A shares their side-effect profile: nausea, vomiting, diarrhea, sweating, muscle twitching, blurred vision and a slow heart rate. The interaction that matters most is with those very drugs; taking huperzine A alongside donepezil or a similar medicine stacks two agents with the same action[6]. Caution also applies with heart-rate-slowing medicines, anticholinergic bladder and allergy drugs, anesthesia, asthma, COPD, epilepsy and stomach ulcers. Approved Alzheimer's treatments are prescribed and monitored by doctors for good reason[7].
What this means for a MindVault buyer
Huperzine A is the last of eight ingredients in MindVault's reference blend, as a 1% extract. That caps it at about 310 mcg, but the true amount could be much smaller; the seller publishes no figure. If you take any dementia, heart or bladder medicine, show the bottle to your pharmacist before the first capsule. If you take none, start with one capsule in the morning and stop at the first sign of a slow pulse, dizziness or persistent stomach upset.
Questions on this topic
Is huperzine A the same as donepezil?
No, but it works the same way: both block acetylcholinesterase. That shared action is why they should not be combined without a prescriber.
How much huperzine A is in MindVault?
The seller does not say. In the reference formula it is the last blend ingredient, which caps it at about 310 mcg of huperzine A per capsule.
Sources linked from this page
Each link opens the original record. The studies tested single ingredients at their own doses, often in people with dementia; none tested a MindVault capsule.
- 1Yang G, Wang Y, Tian J, Liu JP. Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials. PLoS One. 2013;8(9):e74916. pubmed.ncbi.nlm.nih.gov/24086396/
- 2Rafii MS, Walsh S, Little JT, et al. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011;76(16):1389-1394. pubmed.ncbi.nlm.nih.gov/21502597/
- 3Li J, Wu HM, Zhou RL, Liu GJ, Dong BR. Huperzine A for Alzheimer's disease. Cochrane Database Syst Rev. 2008;(2):CD005592. pubmed.ncbi.nlm.nih.gov/18425924/
- 4Ghassab-Abdollahi N, Mobasseri K, Dehghani Ahmadabad A, Nadrian H, Mirghafourvand M. The effects of Huperzine A on dementia and mild cognitive impairment: an overview of systematic reviews. Phytother Res. 2021;35(9):4971-4987. pubmed.ncbi.nlm.nih.gov/33851462/
- 5Xu ZQ, Liang XM, Juan-Wu, et al. Treatment with Huperzine A improves cognition in vascular dementia patients. Cell Biochem Biophys. 2012;62(1):55-58. pubmed.ncbi.nlm.nih.gov/21833673/
- 6MedlinePlus, U.S. National Library of Medicine. Donepezil. medlineplus.gov/druginfo/meds/a697032.html
- 7National Institute on Aging. How Is Alzheimer's Disease Treated? www.nia.nih.gov/health/alzheimers-treatment/how-alzheimers-disease-treated
- 8U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
Run MindVault as a measured 60-day test
The order completes on the brand's own BuyGoods checkout. Before the first capsule, show the bottle to your pharmacist if you take any prescription, note three everyday memory slips you want to track, keep the confirmation email and the return form from the box, and decide by week seven whether to mail the bottles back while the window is still open.